S Cogliatti
Retroperitoneal Mass: Lymphoma as Differential Diagnosis to Retroperitoneal Fibrosis: Case Report
Nussberger M, Kim C, Cogliatti S, Neumann T, Müllhaupt G. Retroperitoneal Mass: Lymphoma as Differential Diagnosis to Retroperitoneal Fibrosis: Case Report. Springerplus 2022; 2022
07.01.2022Retroperitoneal Mass: Lymphoma as Differential Diagnosis to Retroperitoneal Fibrosis: Case Report
07.01.2022Springerplus 2022; 2022
Nussberger Madalina, Kim Chan-Hi Olaf, Cogliatti S, Neumann T, Müllhaupt Gautier
Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK)
Ghielmini M, Cerny T, Wernli M, Ketterer N, Lohri A, Stahel R, Martinelli G, Fey M, Cogliatti S, Léger-Falandry C, Leoncini-Franscini L, Salles G, Rufibach K, Schmitz S. Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005; 16:1675-82.
01.10.2005Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK)
01.10.2005Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005; 16:1675-82
Ghielmini M, Cerny Thomas, Wernli M, Ketterer N, Lohri A, Stahel R, Martinelli G, Fey M, Cogliatti S, Léger-Falandry C, Leoncini-Franscini L, Salles G, Rufibach K, Schmitz S-F Hsu
Accelerated progression of multiple myeloma during anti-CD20 (Rituximab) therapy
Korte W, Jost C, Cogliatti S, Hess U, Cerny T. Accelerated progression of multiple myeloma during anti-CD20 (Rituximab) therapy. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999; 10:1249-50.
01.10.1999Accelerated progression of multiple myeloma during anti-CD20 (Rituximab) therapy
01.10.1999Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999; 10:1249-50
Korte W, Jost C, Cogliatti S, Hess U, Cerny Thomas